Trial Profile
A New Four-day Regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide, and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized Clinical Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2010
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Amoxicillin; Clarithromycin; Dexlansoprazole; Doxycycline; Lansoprazole; Levofloxacin; Moxifloxacin; Omeprazole
- Indications Dyspepsia; Helicobacter pylori infections
- Focus Therapeutic Use
- 15 Nov 2010 New trial record
- 20 Oct 2010 Results were presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology.